{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:17:18Z","timestamp":1783005438055,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"DOI":"10.7759\/cureus.111952","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:52:25Z","timestamp":1783003945000},"source":"Crossref","is-referenced-by-count":0,"title":["Targeted Thyroid Screening in Patients With Vitiligo: A Practical Narrative Review"],"prefix":"10.7759","author":[{"given":"Sri","family":"Naidnur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Iv\u00e1n","family":"Mart\u00ednez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"Vrijman C","year":"2012","unstructured":"Vrijman C, Kroon MW, Limpens J, et al.. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012, 167:1224-35. 10.1111\/j.1365-2133.2012.11198.x","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10717.x","article-title":"Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo","volume":"166","author":"Kroon MW","year":"2012","unstructured":"Kroon MW, Joore IC, Wind BS, et al.. Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo. Br J Dermatol. 2012, 166:532-8. 10.1111\/j.1365-2133.2011.10717.x","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19451","article-title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force part 1: towards a new management algorithm","volume":"37","author":"van Geel N","year":"2023","unstructured":"van Geel N, Speeckaert R, Ta\u00efeb A, et al.. Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol. 2023, 37:2173-84. 10.1111\/jdv.19451","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2018.3449","article-title":"Vitiligo and thyroid disease: a systematic review and meta-analysis","volume":"28","author":"Fan KC","year":"2018","unstructured":"Fan KC, Yang TH, Huang YC. Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol. 2018, 28:750-63. 10.1684\/ejd.2018.3449","journal-title":"Eur J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12122048","article-title":"Vitiligo-thyroid disease association: when, in whom, and why should it be suspected? A systematic review","volume":"12","author":"Chivu AM","year":"2022","unstructured":"Chivu AM, B\u0103l\u0103\u0219escu E, Pandia LD, et al.. Vitiligo-thyroid disease association: when, in whom, and why should it be suspected? A systematic review. J Pers Med. 2022, 12:2048. 10.3390\/jpm12122048","journal-title":"J Pers Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00026-4","article-title":"Estimating the burden of vitiligo: a systematic review and modelling study","volume":"9","author":"Akl J","year":"2024","unstructured":"Akl J, Lee S, Ju HJ, et al.. Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health. 2024, 9:e386-96. 10.1016\/S2468-2667(24)00026-4","journal-title":"Lancet Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine K","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015, 386:74-84. 10.1016\/S0140-6736(14)60763-7","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00290","article-title":"Vitiligo and autoimmune thyroid disorders","volume":"8","author":"Baldini E","year":"2017","unstructured":"Baldini E, Odorisio T, Sorrenti S, et al.. Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne). 2017, 8:290. 10.3389\/fendo.2017.00290","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00803","article-title":"The prevalence of thyroid disorders in patients with vitiligo: a systematic review and meta-analysis","volume":"9","author":"Yuan J","year":"2018","unstructured":"Yuan J, Sun C, Jiang S, et al.. The prevalence of thyroid disorders in patients with vitiligo: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2018, 9:803. 10.3389\/fendo.2018.00803","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.10.021","article-title":"Comorbidities in patients with vitiligo: a systematic review and meta-analysis","volume":"143","author":"Lee JH","year":"2023","unstructured":"Lee JH, Ju HJ, Seo JM, Almurayshid A, Kim GM, Ezzedine K, Bae JM. Comorbidities in patients with vitiligo: a systematic review and meta-analysis. J Invest Dermatol. 2023, 143:777-89.e6. 10.1016\/j.jid.2022.10.021","journal-title":"J Invest Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00670-x","article-title":"Vitiligo","volume":"11","author":"Seneschal J","year":"2025","unstructured":"Seneschal J, Bae JM, Ezzedine K, et al.. Vitiligo. Nat Rev Dis Primers. 2025, 11:85. 10.1038\/s41572-025-00670-x","journal-title":"Nat Rev Dis Primers"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: a review","volume":"330","author":"Lee SY","year":"2023","unstructured":"Lee SY, Pearce EN. Hyperthyroidism: a review. JAMA. 2023, 330:1472-83. 10.1001\/jama.2023.19052","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12166","article-title":"Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms","volume":"168","author":"Gey A","year":"2013","unstructured":"Gey A, Diallo A, Seneschal J, et al.. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br J Dermatol. 2013, 168:756-61. 10.1111\/bjd.12166","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/631927","article-title":"Oxidative stress and immune system in vitiligo and thyroid diseases","volume":"2015","author":"Colucci R","year":"2015","unstructured":"Colucci R, Dragoni F, Moretti S. Oxidative stress and immune system in vitiligo and thyroid diseases. Oxid Med Cell Longev. 2015, 2015:631927. 10.1155\/2015\/631927","journal-title":"Oxid Med Cell Longev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.1643","article-title":"Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease","volume":"20","author":"Spritz RA","year":"2010","unstructured":"Spritz RA. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid. 2010, 20:745-54. 10.1089\/thy.2010.1643","journal-title":"Thyroid"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.05.010","article-title":"Vitiligo and Hashimoto's thyroiditis: autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune\/oxidative stress-mediated toxicity pathogenesis","volume":"128","author":"Li D","year":"2019","unstructured":"Li D, Liang G, Calderone R, Bellanti JA. Vitiligo and Hashimoto's thyroiditis: autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune\/oxidative stress-mediated toxicity pathogenesis. Med Hypotheses. 2019, 128:69-75. 10.1016\/j.mehy.2019.05.010","journal-title":"Med Hypotheses"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19617.x","article-title":"Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin","volume":"119","author":"Slominski A","year":"2002","unstructured":"Slominski A, Wortsman J, Kohn L, et al.. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol. 2002, 119:1449-55. 10.1046\/j.1523-1747.2002.19617.x","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01506-y","article-title":"Prevalence and association of autoimmune comorbidities among adults with vitiligo: a systematic literature review and meta-analysis of USA-based studies","volume":"15","author":"Liu J","year":"2025","unstructured":"Liu J, Matangi S, Malempati Y, Nasir A, Rosmarin D. Prevalence and association of autoimmune comorbidities among adults with vitiligo: a systematic literature review and meta-analysis of USA-based studies. Dermatol Ther (Heidelb). 2025, 15:3109-24. 10.1007\/s13555-025-01506-y","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8065765","article-title":"Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening","volume":"2016","author":"Lazzeri L","year":"2016","unstructured":"Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016, 2016:8065765. 10.1155\/2016\/8065765","journal-title":"Biomed Res Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber JR","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H, et al.. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012, 18:988-1028. 10.4158\/EP12280.GL","journal-title":"Endocr Pract"},{"key":"ref22","article-title":"Thyroid abnormalities in pediatric patients with vitiligo in New York City","volume":"81","author":"Pagovich OE","year":"2008","unstructured":"Pagovich OE, Silverberg JI, Freilich E, Silverberg NB. Thyroid abnormalities in pediatric patients with vitiligo in New York City. Cutis. 2008, 81:463-6.","journal-title":"Cutis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2016.60617","article-title":"Thyroid abnormalities in paediatric patients with vitiligo: retrospective study","volume":"33","author":"Kartal D","year":"2016","unstructured":"Kartal D, Borlu M, \u00c7\u0131nar SL, Kesiko\u011flu A, Uta\u015f S. Thyroid abnormalities in paediatric patients with vitiligo: retrospective study. Postepy Dermatol Alergol. 2016, 33:232-4. 10.5114\/ada.2016.60617","journal-title":"Postepy Dermatol Alergol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000081479","article-title":"Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo","volume":"210","author":"Iacovelli P","year":"2005","unstructured":"Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, Picardo M. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005, 210:26-30. 10.1159\/000081479","journal-title":"Dermatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb A","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M, et al.. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013, 168:5-19. 10.1111\/j.1365-2133.2012.11197.x","journal-title":"Br J Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20596","article-title":"British Association of Dermatologists guidelines for the management of people with vitiligo 2021","volume":"186","author":"Eleftheriadou V","year":"2022","unstructured":"Eleftheriadou V, Atkar R, Batchelor J, et al.. British Association of Dermatologists guidelines for the management of people with vitiligo 2021. Br J Dermatol. 2022, 186:18-29. 10.1111\/bjd.20596","journal-title":"Br J Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist C","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020, 236:571-92. 10.1159\/000506103","journal-title":"Dermatology"},{"key":"ref28","unstructured":"OCEBM Levels of Evidence. (2011). Accessed. June 10, 2026: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506538-targeted-thyroid-screening-in-patients-with-vitiligo-a-practical-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:52:35Z","timestamp":1783003955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506538-targeted-thyroid-screening-in-patients-with-vitiligo-a-practical-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.111952","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}